Skip to content

For Clinicians

Evidence-first non-invasive neutropenia screening.

PointCheck™ is an investigational device for noninvasive assessment of neutropenia risk without a blood draw. This page summarizes the published clinical evidence and how to engage with us as a study site or clinical collaborator.

A clinician reviews a patient's PointCheck™ result on a tablet during a clinic visit.

9

Peer-reviewed publications

8

Collaborating clinical sites

600+

Patients tested to date

0

Blood draws required

Study site collaboration

We partner with academic and community oncology centers on investigator-initiated and sponsor-led studies. Study activities typically include device training, between-cycle monitoring, comparison to CBC ground truth, human factors and usability studies, clinical utility, and health economics evaluations.

If you are interested in evaluating PointCheck™ at your site, please reach out with your indication of interest, patient population, and institutional affiliation.

Inquire about a study Read the evidence

Published evidence

A summary of our most recent peer-reviewed publications.

Full publication list →